Key Points
- Rocket Lab CFO Adam Spice sold 140,157 shares for approximately $8.78 million at an average price of $62.63, reducing his ownership by 10.81% to 1.16 million shares. The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan.
- Rocket Lab’s latest quarterly results showed a $0.08-per-share loss, missing estimates by $0.02, although revenue of $234.1 million exceeded expectations. The company remains unprofitable, with analysts forecasting a full-year loss of $0.20 per share.
- Despite valuation and execution concerns surrounding the delayed Neutron rocket, analyst sentiment remains broadly positive: Rocket Lab has a “Moderate Buy” consensus rating and an average price target of $108.83, while institutional investors own 71.78% of the stock.
Rocket Lab Corporation (NASDAQ:RKLB - Get Free Report) CFO Adam Spice sold 140,157 shares of the firm's stock in a transaction that occurred on Wednesday, September 2nd. The stock was sold at an average price of $62.63, for a total transaction of $8,778,032.91. Following the transaction, the chief financial officer owned 1,155,967 shares in the company, valued at approximately $72,398,213.21. This trade represents a 10.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Rocket Lab Stock Up 0.7%
RKLB stock opened at $64.26 on Friday. The company has a fifty day moving average price of $75.23 and a 200 day moving average price of $84.74. Rocket Lab Corporation has a 12 month low of $37.57 and a 12 month high of $151.00. The company has a market cap of $38.45 billion, a price-to-earnings ratio of -237.99 and a beta of 2.60. The company has a debt-to-equity ratio of 0.01, a current ratio of 5.48 and a quick ratio of 4.98.
Rocket Lab (NASDAQ:RKLB - Get Free Report) last issued its quarterly earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.02). Rocket Lab had a negative return on equity of 6.48% and a negative net margin of 21.51%.The business had revenue of $234.07 million for the quarter, compared to analyst estimates of $231.62 million. Sell-side analysts expect that Rocket Lab Corporation will post -0.2 earnings per share for the current year.
Key Rocket Lab News
Here are the key news stories impacting Rocket Lab this week:
- Positive Sentiment: Berenberg upgraded Rocket Lab to “strong buy.” The bank cited the expanding space economy and the company’s growth prospects, helping improve sentiment after the stock’s sharp recent decline. Why Is RKLB Stock Rising Today and How Much Upside Do Analysts See?
- Positive Sentiment: ARK Invest purchased 705,102 Rocket Lab shares across two trading sessions, according to fund disclosures. Cathie Wood’s buying may be viewed as validation of Rocket Lab’s long-term potential and could attract additional momentum-oriented investors. Cathie Wood Just Bought 705,102 Shares of a Rocket Company 50 Times Smaller Than SpaceX
- Positive Sentiment: Rocket Lab’s commercial base remains substantial. Articles highlighted nearly $2.4 billion in launch backlog, a new major launch contract and the company’s 94th successful launch, including a perfect record on Synspective missions and 16 additional missions booked through 2030. Rocket Lab Scores 94th Launch Win
- Neutral Sentiment: Neutron remains the central investment catalyst. The reusable medium-lift rocket could significantly expand Rocket Lab’s addressable market, but reports suggest its first launch could slip into 2027. The delay would give the company more time for testing but postpone a potentially transformative revenue opportunity. Peter Beck’s Neutron Rocket Could Slip to 2027
- Negative Sentiment: Investors remain concerned about valuation and cash use. Rocket Lab has fallen roughly 49% over three months, while spending ahead of Neutron’s debut. The company remains unprofitable, and its high valuation leaves limited room for execution setbacks. How Long Can Rocket Lab Stock Wait on Neutron?
- Negative Sentiment: Competitive and governance concerns persist. Blue Origin’s win of NASA’s $700 million Mars communications contract highlights intense competition, while a reported $8.8 million CFO share sale and prior analyst skepticism add to investor caution.
Analysts Set New Price Targets
RKLB has been the topic of several recent research reports. TD Cowen boosted their price target on Rocket Lab from $90.00 to $120.00 and gave the company a "buy" rating in a research report on Friday, May 8th. Weiss Ratings reissued a "sell (d-)" rating on shares of Rocket Lab in a report on Friday, July 17th. Stifel Nicolaus set a $132.00 price target on Rocket Lab in a research note on Thursday, June 4th. New Street Research assumed coverage on Rocket Lab in a report on Wednesday, May 13th. They set a "buy" rating and a $150.00 price target for the company. Finally, KGI Securities upgraded shares of Rocket Lab from a "neutral" rating to an "outperform" rating and set a $107.00 price objective on the stock in a research report on Monday, July 27th. Four investment analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Rocket Lab has a consensus rating of "Moderate Buy" and a consensus price target of $108.83.
Get Our Latest Analysis on Rocket Lab
Institutional Investors Weigh In On Rocket Lab
A number of hedge funds have recently added to or reduced their stakes in RKLB. Parkside Financial Bank & Trust boosted its holdings in Rocket Lab by 669.1% in the 2nd quarter. Parkside Financial Bank & Trust now owns 6,022 shares of the rocket manufacturer's stock valued at $612,000 after purchasing an additional 5,239 shares in the last quarter. Anchor Capital Advisors LLC purchased a new position in shares of Rocket Lab during the 2nd quarter worth approximately $1,421,000. Corient Private Wealth LP raised its stake in shares of Rocket Lab by 795.2% during the 2nd quarter. Corient Private Wealth LP now owns 476,241 shares of the rocket manufacturer's stock worth $48,410,000 after buying an additional 423,039 shares in the last quarter. Amundi raised its stake in shares of Rocket Lab by 22.2% during the 2nd quarter. Amundi now owns 2,180,748 shares of the rocket manufacturer's stock worth $221,673,000 after buying an additional 396,639 shares in the last quarter. Finally, HighTower Advisors LLC lifted its holdings in shares of Rocket Lab by 4.2% in the 2nd quarter. HighTower Advisors LLC now owns 109,226 shares of the rocket manufacturer's stock valued at $11,103,000 after buying an additional 4,407 shares during the period. Institutional investors and hedge funds own 71.78% of the company's stock.
About Rocket Lab
(
Get Free Report)
Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company's primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company's propulsion capabilities.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
